Advisory Committee on Immunization Practices, 3709-3710 [05-1389]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 16 / Wednesday, January 26, 2005 / Notices
have access to the smallpox virus and
attempt to use it against the American
public and U.S. Government facilities
abroad.
II. Amendment of Declaration
I, Claude A. Allen, Acting Secretary of
the Department of Health and Human
Services, have concluded, in accordance
with the authority vested in me under
section 224(p)(2)(A) of the Public Health
Service Act, that a potential bioterrorist
incident makes it advisable to extend
the January 24, 2003 declaration, as
amended, regarding administration of
smallpox countermeasures until and
including January 23, 2006. The January
24, 2003, declaration, as amended, may
be further amended as circumstances
require.
III. Effective Dates
This extension is effective January 24,
2005 until and including January 23,
2006. The effective period may be
extended or shortened by subsequent
amendment to the January 24, 2003,
declaration.
Dated: January 21, 2005.
Claude A. Allen,
Acting Secretary.
[FR Doc. 05–1479 Filed 1–25–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces the following committee
meeting.
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates:
8:30 a.m.–5 p.m., February 16, 2005.
8:30 a.m.–3 p.m., February 17, 2005.
Place: Doubletree Hotel (Atlanta/
Buckhead), 3342 Peachtree Rd. NE., Atlanta,
Georgia 30326, Telephone: (404) 231–1234.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated; the impact on medical and
laboratory practice of proposed revisions to
VerDate jul<14>2003
19:33 Jan 25, 2005
Jkt 205001
the standards; and the modification of the
standards to accommodate technological
advances.
Matters To Be Discussed: The agenda will
include updates from the Food and Drug
Administration, the Centers for Medicare &
Medicaid Services, and the Centers for
Disease Control and Prevention;
implementation of cytology proficiency
testing for individuals; a report from the
CLIAC Workgroup on Good Laboratory
Practices for Waived Testing, and discussion
of the Workgroup’s proposals related to such;
and an introduction to appropriate quality
control for diverse and evolving test systems,
including microbiology identification
systems. Agenda items are subject to change
as priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible. Oral
Comments: In general, each individual or
group requesting to make an oral
presentation will be limited to a total time of
five minutes (unless otherwise indicated).
Speakers must also submit their comments in
writing for inclusion in the meeting’s
Summary Report. To assure adequate time is
scheduled for public comments, individuals
or groups planning to make an oral
presentation should, when possible, notify
the contact person below at least one week
prior to the meeting date. Written Comments:
For individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, the
comments should be received at least one
week prior to the meeting date so that the
comments may be made available to the
Committee for their consideration and public
distribution. Written comments, one hard
copy with original signature, should be
provided to the contact person below.
Written comments will be included in the
meeting’s Summary Report.
Contact Person for Additional Information:
Rhonda Whalen, Chief, Laboratory Practice
Standards Branch, Division of Laboratory
Systems, Office of Public Health
Partnerships, CDC, 4770 Buford Highway,
NE, Mailstop F–11, Atlanta, Georgia 30341–
3717; telephone (770) 488–8042; fax (770)
488–8279; or via e-mail at RWhalen@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: January 20, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–1390 Filed 1–25–05; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
3709
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announce the following Federal
Committee meeting.
Name: Advisory Committee on
Immunization Practices (ACIP).
Times and Dates:
8 a.m.–6:30 p.m., February 10, 2005.
8 a.m.–4:30 p.m., February 11, 2005.
Place: Atlanta Marriott Century Center,
2000 Century Boulevard, N.E., Atlanta,
Georgia 30345–3377.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
Committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters To Be Discussed: The agenda will
include discussions on Hepatitis B vaccine
recommendations; recommendations of use
of Hepatitis A vaccine; Human Papilloma
Virus vaccine working group update;
Meningococcal conjugate vaccine and
possible VFC vote on meningococcal vaccine
use if the vaccine is licensed; varicella
prevention; influenza vaccine
recommendations for 2005; pertussis vaccine
booster dose policy; polio outbreak response
and stockpile planning; revisions to the
general recommendations; yellow fever
vaccine safety work group update; proposal
for use of Evidence-based recommendations;
rotavirus vaccine update; and Departmental
updates.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Demetria Gardner, Epidemiology and
Surveillance Division, National
Immunization Program, CDC, 1600 Clifton
Road, NE., (E–61), Atlanta, Georgia 30333,
telephone (404) 639–8096, fax (404) 639–
8616.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
E:\FR\FM\26JAN1.SGM
26JAN1
3710
Federal Register / Vol. 70, No. 16 / Wednesday, January 26, 2005 / Notices
Dated: January 20, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–1389 Filed 1–25–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Child Care and Development
Fund Annual Financial Report for
Tribes (ACF–696T).
OMB No.: 0970–0195.
Description: The Child Care and
Development Fund (CCDF) annual
financial reporting form (ACF–696T)
provides a mechanism for Indian tribes
to report expenditures under the CCDF
program. The CCDF program provides
funds to tribes, as well as States and
Territories, to assist low-income
families in obtaining child care so that
they can work or attend training/
education, and to improve the quality of
care. Information collected via the ACF–
696T allows the Administration for
Children and Families (ACF) to monitor
expenditures and to estimate outlays,
and may be used to prepare ACF budget
submissions to Congress. The proposed
information collection is identical to the
currently used ACF–696T form for
which the Office of Management and
Budget (OMB) approval expires on
March 31, 2005.
Respondents: Indian tribes and tribal
organizations that are CCDF grantees.
ANNUAL BURDEN ESTIMATES
Instrument
Number of respondents
Number of responses per
respondent
Average
burden hours
per response
Total burden
hours
ACF–696T CCDF Financial Reporting Form for Tribes ..................................
232
1
7.5
1,740
Estimated Total Annual Burden
Hours: 1,740.
Additional Information: Copies of the
proposed collection may be obtained by
writing to The Administration for
Children and Families, Office of
Information Services, 730 L’Enfant
Promenade, SW., Washington, DC
20447, Attn: ACF Reports Clearance
Officer.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Attn: Desk Officer for
ACF, e-mail address:
Katherine_T.Astrich@omb.eop.
Dated: January 18, 2005.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 05–1397 Filed 1–25–05; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request Proposed
Projects
Title: LIHEAP Quarterly Allocation
Estimates.
OMB No.: 0970–0037.
Description: The Low Income Home
Energy Assistance Program (LIHEAP)
Quarterly Allocation Estimates Form–
535 is a one-page form that is sent to 50
State grantees and the District of
Columbia. It is also sent to tribal
grantees that receive over $1 million
annually and that directly administer
the LIHEAP Program. Grantees are asked
to complete and submit the form in the
4th quarter of every fiscal year. The data
collected on the form are the grantee’s
estimates of obligations that they expect
to make each quarter during the
upcoming fiscal year. This is the only
method used to request anticipate
distribution of the grantee’s LIHEAP
funds for the program year. The
information is used to disburse LIHEAP
funds in accordance with grantee needs
and to develop OMB apportionment
requests.
Respondents: State, local or tribal
Government.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Form ACF–535 ................................................................................................
55
1
.25
13.75
Estimated Total Annual Burden
Hours: 13.75.
In compliance with the requirements
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
VerDate jul<14>2003
19:33 Jan 25, 2005
Jkt 205001
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Information Services,
370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Reports Clearance Officer. E-mail:
grjohnson@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) whether the proposed
collection of information is necessary
for the proper performance of the
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 70, Number 16 (Wednesday, January 26, 2005)]
[Notices]
[Pages 3709-3710]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following Federal Committee meeting.
Name: Advisory Committee on Immunization Practices (ACIP).
Times and Dates:
8 a.m.-6:30 p.m., February 10, 2005.
8 a.m.-4:30 p.m., February 11, 2005.
Place: Atlanta Marriott Century Center, 2000 Century Boulevard,
N.E., Atlanta, Georgia 30345-3377.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters To Be Discussed: The agenda will include discussions on
Hepatitis B vaccine recommendations; recommendations of use of
Hepatitis A vaccine; Human Papilloma Virus vaccine working group
update; Meningococcal conjugate vaccine and possible VFC vote on
meningococcal vaccine use if the vaccine is licensed; varicella
prevention; influenza vaccine recommendations for 2005; pertussis
vaccine booster dose policy; polio outbreak response and stockpile
planning; revisions to the general recommendations; yellow fever
vaccine safety work group update; proposal for use of Evidence-based
recommendations; rotavirus vaccine update; and Departmental updates.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Demetria Gardner,
Epidemiology and Surveillance Division, National Immunization
Program, CDC, 1600 Clifton Road, NE., (E-61), Atlanta, Georgia
30333, telephone (404) 639-8096, fax (404) 639-8616.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the CDC and ATSDR.
[[Page 3710]]
Dated: January 20, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-1389 Filed 1-25-05; 8:45 am]
BILLING CODE 4163-18-P
